Share This Author
Antipsychotic treatment of primary delusional parasitosis
- P. Lepping, I. Russell, R. Freudenmann
- Medicine, PsychologyBritish Journal of Psychiatry
- 1 September 2007
Analysis of selected patients with primary delusional parasitosis showed that typical and atypical antipsychotics were effective in the majority, but that remission rates did not differ significantly between typical andAtypical anti-psychotic drugs.
Pregabalin abuse and dependence in Germany: results from a database query
- M. Gahr, R. Freudenmann, C. Hiemke, M. Kölle, C. Schönfeldt-Lecuona
- Medicine, PsychologyEuropean Journal of Clinical Pharmacology
- 5 January 2013
The aim of this study was to identify the number of cases of PRG abuse or dependence reported to the database of a German medical regulatory body and to obtain insights into further usage-specific parameters.
SUMMARY This papers aims at familiarizing psychiatric and nonpsychiatric readers with delusional infestation (DI), also known as delusional parasitosis. It is characterized by the fixed belief of…
Neural Correlates of Error Monitoring Modulated by Atomoxetine in Healthy Volunteers
Desomorphine Goes “Crocodile”
- M. Gahr, R. Freudenmann, C. Hiemke, I. Gunst, B. Connemann, C. Schönfeldt-Lecuona
- MedicineJournal of addictive diseases
- 1 October 2012
Krokodil seems to be a mixture of several substances and was first used in Russia in 2003, with a tremendous increase in the number of addicted individuals since then.
Second-Generation Antipsychotics in Primary and Secondary Delusional Parasitosis: Outcome and Efficacy
This first retrospective case-based study provides low-level evidence that SGAs are effective in DP and that outcome is favorable, although a publication bias is likely.
The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents.
The true story of the first known description of MDMA at Merck is reconstructed using the original documents to reveal that uncritical copy-paste procedures may have contributed to the famous myth that MDMA was patented as an appetite suppressor in 1912.
Concerns about pregabalin: further experience with its potential of causing addictive behaviors.
- M. Gahr, B. Franke, R. Freudenmann, M. Kölle, C. Schönfeldt-Lecuona
- Medicine, PsychologyJournal of addiction medicine
- 1 March 2013
The case of a 38-year-old female patient with borderline personality disorder and past alcohol abuse who developed PRG abuse is reported, illustrating the possibility of PRG to trigger the development of addictive behaviors and should encourage physicians to be very careful when administeringPRG to patients with current or past substance-related disorders.
Aerobic endurance exercise improves executive functions in depressed patients.
- S. Kubesch, V. Bretschneider, G. Grön
- Psychology, MedicineThe Journal of clinical psychiatry
- 15 September 2003
A single 30-minute aerobic endurance exercise program performed by depressed patients has positive effects on executive control processes that appear to be specifically subserved by the anterior cingulate.
Accuracy of Stereotaxic Positioning of Transcranial Magnetic Stimulation
- C. Schönfeldt-Lecuona, A. Thielscher, R. Freudenmann, M. Kron, M. Spitzer, U. Herwig
- BiologyBrain Topography
- 1 June 2005
Summary:In cognitive neuroscience, optically tracked frameless stereotaxic navigation has been successfully used to precisely guide transcranial magnetic stimulation (TMS) to desired cortical areas…